M.Preusser summarises results from different trials exploring the use of bevacizumab in brain tumours in adults, highlighting the potential of anti-angiogenesis drugs in this disease and warning on the need to precisely figure out which patients really benefit from this approach.
Bevacizumab in glioblastoma: clinical and imaging aspects
Share
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in brain tumours. Part 2 of 2. Questions 1. What are the most promising agents targeting […]
Mark CompleteCompleted
BookmarkBookmarked
Riccardo Soffietti (EAN Programme Committee; Chairman, Department of Neuro-Oncology, University and City of Health and Science Hospital, Turini, Italy) talks to us about the topic of the symposium he participated in entitled: Advances in molecular characterisation and personalised therapies in ...
Mark CompleteCompleted
BookmarkBookmarked
EAN Programme Committee Member, Prof. Riccardo Soffietti, provides his insights on neuro-oncology coverage at this year’s EAN congress. Part 3 of 3. View Part 1 here. View Part 2 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at ...
Mark CompleteCompleted
BookmarkBookmarked
EAN Programme Committee Member, Prof. Riccardo Soffietti, talks about unmet needs and what he considers will be the most exciting/promising developments in neuro-oncology over the next 2 years. Part 2 of 3. View Part 1 here. View Part 3 here. Speaker disclosures: nothing to ...
Mark CompleteCompleted
BookmarkBookmarked
EAN Programme Committee Member, Prof. Riccardo Soffietti, discusses the most significant recent developments in neuro-oncology. Part 1 of 3. View Part 2 here. View Part 3 here. Speaker disclosures: nothing to disclose in relation to this video interview. Filmed at the 3rd Congress of ...
Mark CompleteCompleted
BookmarkBookmarked
NEW
M.M. Thurnher discusses brain tumour radiology at ECR 2014.
Mark CompleteCompleted
BookmarkBookmarked
Kurt Jaeckle, MD, professor of neurology and oncology, Mayo Clinic, discusses radiosurgery versus radiotherapy followed by whole brain radiation for brain metastases.
Mark CompleteCompleted
BookmarkBookmarked
Dr Buckner (Mayo Clinic, Rochester, USA) presents, at a press conference at ASCO 2015, a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive ...
Mark CompleteCompleted
BookmarkBookmarked
Demonstration of the benefits and limitations of fluorescent guided surgery for resection of glioblastoma.
Mark CompleteCompleted
BookmarkBookmarked
The UF Health Cancer Center at Orlando is one of very few centers in the southeast to offer dedicated neuro oncology, neuro radiation oncology, and tumor neurosurgery teams that specialize in treating brain and spine tumors.
Mark CompleteCompleted
BookmarkBookmarked
From ASCO 2014, Dr. Annick Desjardins of Duke University discusses the retrospective focus on glioblastoma treatment and the use of bevacizumab.
Mark CompleteCompleted
BookmarkBookmarked
The ways in which mice can be used to investigate the causes of malignant brain tumours.
Mark CompleteCompleted
BookmarkBookmarked
Susan Challinor, MD, an endocrinologist at UPMC, discusses the diagnosis and treatment of pituitary adenomas and details why a multidisciplinary approach should be considered.
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
